Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-01-02 @ 10:50 AM
Study NCT ID:
NCT07286292
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S.)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
S095032-236
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None